amphetamine has been researched along with Recrudescence in 24 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Preliminary evidence suggest clozapine is associated with more favorable impact on concurrent substance use disorder related outcomes in patients with concurrent schizophrenia spectrum disorders (SSD)." | 8.31 | Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study. ( Bousman, CA; Danilewitz, M; Frankow, L; Honer, WG; Mahmood, H; Mathew, N; Poonia, S; Rafizadeh, R; Schütz, CG, 2023) |
| "Forty-four patients presenting with first-ever seizure within 24 h of illicit use of amphetamine or related analogs (amphetamine-associated seizures, AAS) were identified over 8 years." | 7.77 | Amphetamine-associated seizures: clinical features and prognosis. ( Brown, JW; Dunne, JW; Fatovic, DM; Fatovich, DM; Lawn, ND; Lee, J, 2011) |
| "Adenosine monophosphate pretreatment of mice with latent herpes simplex virus type 1 infections significantly reduced the rate of reactivation of latent virus." | 7.66 | Effects of adenosine monophosphate on the reactivation of latent herpes simplex virus type 1 infections of mice. ( Blue, WT; Kirksey, DF; Savage, RE; Stobbs, DG; Winland, RD, 1981) |
| "Preliminary evidence suggest clozapine is associated with more favorable impact on concurrent substance use disorder related outcomes in patients with concurrent schizophrenia spectrum disorders (SSD)." | 4.31 | Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study. ( Bousman, CA; Danilewitz, M; Frankow, L; Honer, WG; Mahmood, H; Mathew, N; Poonia, S; Rafizadeh, R; Schütz, CG, 2023) |
| "Forty-four patients presenting with first-ever seizure within 24 h of illicit use of amphetamine or related analogs (amphetamine-associated seizures, AAS) were identified over 8 years." | 3.77 | Amphetamine-associated seizures: clinical features and prognosis. ( Brown, JW; Dunne, JW; Fatovic, DM; Fatovich, DM; Lawn, ND; Lee, J, 2011) |
| "Adenosine monophosphate pretreatment of mice with latent herpes simplex virus type 1 infections significantly reduced the rate of reactivation of latent virus." | 3.66 | Effects of adenosine monophosphate on the reactivation of latent herpes simplex virus type 1 infections of mice. ( Blue, WT; Kirksey, DF; Savage, RE; Stobbs, DG; Winland, RD, 1981) |
| "Amphetamine (AMPH) is a psychostimulant drug frequently related to addiction, which is characterized by functional and molecular changes in the brain reward system, favoring relapse development, and pharmacotherapies have shown low effectiveness." | 1.72 | Tactile Stimulation in Adult Rats Modulates Dopaminergic Molecular Parameters in the Nucleus accumbens Preventing Amphetamine Relapse. ( Burger, ME; D'Àvila, LF; Metz, VG; Milanesi, LH; Rosa, HZ; Rosa, JLO; Rossato, DR, 2022) |
| "Amphetamine (AMPH) is an addictive psychostimulant highly used worldwide and its consumption is related to neurotoxic effects." | 1.62 | Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats. ( Burger, ME; da Rosa, JLO; Metz, VG; Milanesi, LH; Pase, CS; Rossato, DR, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 6 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Segat, HJ | 1 |
| Martini, F | 1 |
| Roversi, K | 1 |
| Rosa, SG | 1 |
| Muller, SG | 1 |
| Rossato, DR | 4 |
| Nogueira, CW | 1 |
| Burger, ME | 4 |
| Rosa, HZ | 1 |
| Rosa, JLO | 1 |
| Milanesi, LH | 2 |
| Metz, VG | 3 |
| D'Àvila, LF | 1 |
| da Rosa, JLO | 2 |
| Pase, CS | 2 |
| Karimi-Haghighi, S | 1 |
| Mahmoudi, M | 1 |
| Sayehmiri, F | 1 |
| Mozafari, R | 1 |
| Haghparast, A | 1 |
| Rafizadeh, R | 1 |
| Frankow, L | 1 |
| Mahmood, H | 1 |
| Poonia, S | 1 |
| Mathew, N | 1 |
| Danilewitz, M | 1 |
| Bousman, CA | 1 |
| Honer, WG | 1 |
| Schütz, CG | 1 |
| Brown, JW | 1 |
| Dunne, JW | 1 |
| Fatovich, DM | 1 |
| Fatovic, DM | 1 |
| Lee, J | 1 |
| Lawn, ND | 1 |
| Nishikawa, T | 1 |
| Blue, WT | 1 |
| Winland, RD | 1 |
| Stobbs, DG | 1 |
| Kirksey, DF | 1 |
| Savage, RE | 1 |
| Nakayama, M | 1 |
| Ragland, AS | 1 |
| Ismail, Y | 1 |
| Arsura, EL | 1 |
| Skurtveit, S | 1 |
| Christophersen, AS | 1 |
| Beylich, KM | 1 |
| Mørland, J | 1 |
| Wang, B | 1 |
| Luo, F | 1 |
| Zhang, WT | 1 |
| Han, JS | 1 |
| Weintraub, D | 1 |
| Linder, MW | 1 |
| Post, RM | 1 |
| Kopanda, RT | 1 |
| Langer, G | 1 |
| Heinze, G | 1 |
| Reim, B | 1 |
| Matussek, N | 1 |
| Angrist, B | 1 |
| Peselow, E | 1 |
| Rubinstein, M | 1 |
| Wolkin, A | 1 |
| Rotrosen, J | 1 |
| Simpson, DD | 1 |
| Sells, SB | 1 |
| Stanton, MD | 1 |
| Bardoni, A | 1 |
| Dalai, O | 1 |
| Jones, BE | 1 |
| Prada, JA | 1 |
| Young, GC | 1 |
| Morgan, RT | 1 |
| Gunne, LM | 1 |
| Götestam, KG | 1 |
| Blachly, PH | 1 |
3 reviews available for amphetamine and Recrudescence
| Article | Year |
|---|---|
Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies.
Topics: Amphetamine; Animals; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Cocaine; | 2023 |
[Genetic study on schizophrenia and its recurrence utilizing pharmacological models].
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Disease Models, Animal; Dopamine A | 2002 |
Cocaine, kindling, and psychosis.
Topics: Amphetamine; Cocaine; Drug Tolerance; Electric Stimulation; Epilepsy, Temporal Lobe; Humans; Lidocai | 1976 |
21 other studies available for amphetamine and Recrudescence
| Article | Year |
|---|---|
Impact of two different types of exercise training on AMPH addiction: Role of hippocampal neurotrophins.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain-Derived Neurotrophic Factor; Hippocampus; | 2022 |
Tactile Stimulation in Adult Rats Modulates Dopaminergic Molecular Parameters in the Nucleus accumbens Preventing Amphetamine Relapse.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dopamine; Male; Nucleus Accumbens; Rats; Re | 2022 |
Cannabidiol treatment prevents drug reinstatement and the molecular alterations evoked by amphetamine on receptors and enzymes from dopaminergic and endocannabinoid systems in rats.
Topics: Amphetamine; Animals; Cannabidiol; Dopamine; Endocannabinoids; Rats; Recurrence | 2022 |
Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
Topics: Amphetamine; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Female; Humans; Mal | 2023 |
Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Brain; Cannabidiol; Central Nervous System Stim | 2021 |
Amphetamine-associated seizures: clinical features and prognosis.
Topics: Adolescent; Adult; Amphetamine; Anticonvulsants; Central Nervous System Stimulants; Electroencephalo | 2011 |
Effects of adenosine monophosphate on the reactivation of latent herpes simplex virus type 1 infections of mice.
Topics: Adenosine Monophosphate; Amphetamine; Animals; Herpes Simplex; Mice; Mice, Inbred Strains; Recurrenc | 1981 |
[Changes of the dopamine uptake sites in the rat striatum induced by repeated methamphetamine administration: a neurochemical approach to a mechanism of relapse in amphetamine psychosis].
Topics: Amphetamine; Animals; Behavior, Animal; Benzamides; Benzazepines; Binding Sites; Corpus Striatum; Do | 1993 |
Myocardial infarction after amphetamine use.
Topics: Adult; Amphetamine; Coronary Angiography; Echocardiography; Electrocardiography; Female; Humans; Myo | 1993 |
[Repeated driving under influence].
Topics: Alcohol Drinking; Amphetamine; Automobile Driving; Central Nervous System Stimulants; Ethanol; Femal | 1999 |
Stress or drug priming induces reinstatement of extinguished conditioned place preference.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Conditioning, Psychological; Electroshock; | 2000 |
Amphetamine positive toxicology screen secondary to bupropion.
Topics: Aged; Amphetamine; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Chromatogr | 2000 |
Reduced growth hormone responses to amphetamine in "endogenous" depressive patients: studies in normal, "reactive" and "endogenous" depressive, schizophrenic, and chronic alcoholic subjects.
Topics: Adjustment Disorders; Adult; Aged; Alcoholism; Amphetamine; Blood Pressure; Chronic Disease; Depress | 1976 |
Amphetamine response and relapse risk after depot neuroleptic discontinuation.
Topics: Adult; Amphetamine; Antipsychotic Agents; Delayed-Action Preparations; Female; Fluphenazine; Humans; | 1985 |
Patterns of multiple drug abuse: 1969-1971.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Barbiturates; Black or African American; Cannabis; Coca | 1974 |
Drug flashbacks: reported frequency in a military population.
Topics: Adult; Amphetamine; Birth Order; Cannabis; Hallucinations; Humans; Lysergic Acid Diethylamide; Male; | 1972 |
[Genetic factors in the recurrent confusional psychoses].
Topics: Amphetamine; Bipolar Disorder; Cognition Disorders; Humans; Lysergic Acid Diethylamide; Mental Proce | 1972 |
Relapse to morphine use in dog.
Topics: Amphetamine; Animals; Disease Models, Animal; Dogs; Humans; Morphine; Morphine Dependence; Recurrenc | 1973 |
Conditioning techniques and enuresis.
Topics: Acoustic Stimulation; Amphetamine; Attitude of Health Personnel; Behavior Therapy; Child; Child Beha | 1973 |
[A follow-up study of amphetamine addicts participating in clinical drug studies].
Topics: Amphetamine; Appetite Depressants; Female; Follow-Up Studies; Humans; Male; Recurrence; Substance-Re | 1972 |
Recent developments in the therapy of addictions.
Topics: Amphetamine; Aversive Therapy; Barbiturates; Cocaine; Hallucinogens; Humans; Methadone; Nicotiana; O | 1972 |